Snehal brings a confluence of early discovery, innovation and scientific expertise to her current role of North America regulatory liaison for cell & gene therapies and microbiome at Janssen.With a keen interest in influencing policy, she staffs the regulatory committee, gene therapy & genome editing groups of the Alliance for Regenerative Medicine, and is an active member of the American Society of Gene & Cell Therapy and New York Academy of Sciences. Snehal graduated summa cum laude with an AB-MA in Biology from Bryn Mawr College, and holds a Ph.D. in Molecular Genetics & Genomics from Washington University in St Louis.